KLP Kapitalforvaltning’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$102K Hold
14,000
– – ﹤0.01% 2077
2026
Q2
$152K Hold
14,000
– – ﹤0.01% 1989
2026
Q1
$156K Hold
14,000
– – ﹤0.01% 1913
2025
Q4
$232K Buy
+14,000
New +$200K ﹤0.01% 1784
2025
Q2
– Sell
-9,100
Closed -$57.1K – 2250
2025
Q1
$57.1K Hold
9,100
– – ﹤0.01% 2177
2024
Q4
$73.9K Buy
+9,100
New +$113K ﹤0.01% 2178

Other funds holding PHAT

KLP Kapitalforvaltning's PHAT Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Phathom Pharmaceuticals (PHAT) position steady in Q3 2026 at 14,000 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

KLP Kapitalforvaltning first reported a position in PHAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $232K in Q4 2025. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.

  • KLP Kapitalforvaltning held 14,000 shares of Phathom Pharmaceuticals worth $102K as of Q3 2026.
  • KLP Kapitalforvaltning left its Phathom Pharmaceuticals share count unchanged in Q3 2026.
  • Phathom Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #2077 holding.
  • KLP Kapitalforvaltning first reported a position in Phathom Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • KLP Kapitalforvaltning's Phathom Pharmaceuticals position peaked at $232K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.